Supplier News Breaks Archives
McNeil recalls Tylenol infant oral suspension
February 17th, 2012
FORT WASHINGTON, Pa. – McNeil Consumer Healthcare is voluntarily recalling about 574,000 bottles of Infants' Tylenol Oral Suspension pain reliever/fever reducer, citing concerns about the syringe dosing system.
The McNeil-PPC Inc. division said Friday that its calling back seven lots at the wholesale and retail level of Infants' Tylenol Oral Suspension 1 oz. Grape distributed nationwide in the United States.
McNeil noted that it's initiating the recall as a precaution after receiving a small number of complaints from consumers who reported difficulty using the product's SimpleMeasure dosing system.
SimpleMeasure includes a dosing syringe, which a parent or caregiver inserts into a protective cover, or "flow restrictor," at the top of the bottle to measure the proper dose. In some cases, the flow restrictor was pushed into the bottle when inserting the syringe, according to McNeil.
Children's Tylenol products are intended for children 2 years of age and older and remain available, the company said.
No adverse events associated with the recall action have been reported, and the risk of a serious adverse medical event is remote, McNeil stated, adding that consumers can continue to use Infants' Tylenol as long as the flow restrictor at the top of the bottle remains in place.